Infectious Diseases

Roy M. Gulick, M.D., M.P.H., Chief

Welcome to the Weill Cornell Medicine Division of Infectious Diseases (ID). Our mission is to design and conduct cutting edge research, to deliver outstanding clinical care, and to provide the highest quality education and training in infectious diseases. We have 60 full-time faculty members, and our division includes basic, translational, clinical and epidemiological research programs, inpatient and ambulatory clinical services at NewYork Presbyterian Hospital/Weill Cornell Medical Center, and the ID Fellowship Training Program.

Research

The main laboratory research projects in our division focus on antibiotic and antifungal drug development, bacterial pathogenesis, HIV and other retroviruses, influenza, malaria/babesia, and tuberculosis. Major clinical research projects investigate antimicrobial drug resistance, hepatitis, HIV/AIDS, hospital epidemiology/infection control, human papillomavirus, respiratory viruses, and transplantation/oncology ID. Furthermore, in collaboration with The Center for Global Health, we have clinical, research and training programs in Brazil, Haiti, and Tanzania, with full-time faculty and/or fellows at each site. Overseas research interests at these locations include diarrheal illnesses, HIV/AIDS, HTLV-1, leprosy, malaria, leishmaniasis, schistosomiasis, and tuberculosis.

Since the beginning of the COVID-19 pandemic, our division has been engaged in research on SARS-CoV-2/COVID-19 pathogenesis, therapeutics, epidemiology/outcomes, and vaccine development. Additionally, ID division members are leading national research to understand the effectiveness of antiviral therapy for Mpox.

Current annual funding for all of the sponsored research and training in the Division of Infectious Diseases in 2022-2023 exceeds $37 million.

Please refer to the  Infectious Disease Division Brochure for additional details.